Shield Therapeutics (LON:STX) Share Price Passes Below 50-Day Moving Average – What’s Next?

Shield Therapeutics plc (LON:STX)’s stock price passed below its 50-day moving average during trading on Friday . The stock has a 50-day moving average of GBX 2.70 ($0.03) and traded as low as GBX 2.60 ($0.03). Shield Therapeutics shares last traded at GBX 2.80 ($0.03), with a volume of 1,741,134 shares changing hands.

Shield Therapeutics Stock Up 3.7 %

The company has a 50-day moving average price of GBX 2.70 and a 200 day moving average price of GBX 3.27. The firm has a market capitalization of £21.90 million, a PE ratio of -70.00 and a beta of 1.42. The company has a debt-to-equity ratio of 3,691.50, a current ratio of 1.05 and a quick ratio of 2.16.

About Shield Therapeutics

Shield is a commercial-stage specialty pharmaceutical company that delivers Accrufer®/Feraccru® (ferric maltol), an innovative and differentiated pharmaceutical product, to address a significant unmet need for patients suffering from iron deficiency, with or without anemia. The Company has launched Accrufer® in the U.S.